Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: B-Lunist
1
Apr 29, 2008 07:34PM
2
Apr 29, 2008 08:10PM

Apr 30, 2008 04:26AM
11
Apr 30, 2008 09:01AM
2
Apr 30, 2008 10:34AM

Re: B-Lunist

posted on Apr 30, 2008 10:47AM

When it is done the Authorized shares stay the same, moxa

<<<<<<<<<...

You say that like it is a fact. It isn't. All shares are treated the same. They are all lessened (in the case of a RS) or increased (in the case of a forward split)

This reverse split will give Summus approximately 13.4 million shares of common stock outstanding. The Company's number of authorized shares of common stock will remain at 185,000,000, and its number of authorized shares of preferred stock will remain at 5,000,000.

http://findarticles.com/p/articles/m...

Be well


Apr 30, 2008 11:32AM
2
Apr 30, 2008 11:33AM

Apr 30, 2008 11:34AM
Share
New Message
Please login to post a reply